Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.74 USD | -0.38% | +1.75% | +4.31% |
05-20 | Entrada Therapeutics Insider Sold Shares Worth $287,695, According to a Recent SEC Filing | MT |
05-16 | Entrada Therapeutics Insider Bought Shares Worth $364,673, According to a Recent SEC Filing | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.31% | 500M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- TRDA Stock
- News Entrada Therapeutics, Inc.
- Transcript : Entrada Therapeutics, Inc. Presents at Goldman Sachs 43rd Annual Global Healthcare Conference, Jun-14-2022 02